MySize Issues CEO Letter to Stockholders

MySize (NASDAQ: MYSZ) CEO Ronen Luzon notified shareholders that Nasdaq issued a notice for failure to meet the $1.00 minimum bid price, giving the company until August 31, 2026 to regain compliance.

Rhea-AI Summary

MySize (NASDAQ: MYSZ) CEO Ronen Luzon notified shareholders that Nasdaq issued a notice for failure to meet the $1.00 minimum bid price, giving the company until August 31, 2026 to regain compliance. The company reported ~$10 million revenue for 2025 and detailed business units: Orgad, Naiz Fit, Percentil, and 10peaks.

Orgad delivered ~40% gross margins in 2025; 10peaks posted ~$150,000 revenue with ~65% gross margins and management estimates ~$3 million annual revenue under current assumptions.

Positive

• Total revenue approximately $10 million in 2025
• Orgad delivered approximately 40% gross margins in 2025
• 10peaks achieved approximately 65% gross margins before expenses
• Management estimates $3 million annual revenue potential for 10peaks

Negative

• Nasdaq notice: closing bid below $1.00 for 30 trading days
• Company must regain $1.00 bid by August 31, 2026 or face delisting risk
• 10peaks 2025 revenue was only $150,000, indicating early-stage sales

Argus Mar 3 session

+0.46% close to close Open Argus

Details

News Market Reaction – MYSZ

In the Mar 3 session, MYSZ gained 0.46%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement combines a Nasdaq minimum bid price deficiency notice with a strategic update on M...

Analysis

This announcement combines a Nasdaq minimum bid price deficiency notice with a strategic update on MySize’s operations. Management reports ~$10 million in 2025 revenue, with Orgad and 10peaks delivering attractive gross margins and forming a base for higher‑margin growth. At the same time, the company has until August 31, 2026 to restore a $1.00 bid for 10 consecutive days. Investors may watch revenue mix shifts, 10peaks scaling toward its $3 million estimate, and any steps taken to regain compliance.

Key Figures

2025 revenue: approximately $10 million Orgad gross margin: approximately 40% 10peaks 2025 revenue: approximately $150,000 +5 more

2025 revenue

approximately $10 million

MySize revenue across platform in 2025

Orgad gross margin

approximately 40%

Year ended December 31, 2025

10peaks 2025 revenue

approximately $150,000

Year ended 2025

10peaks gross margin

approximately 65%

Before operating expenses, year ended 2025

10peaks estimated revenue

approximately $3 million annually

Management estimate based on current assumptions

Nasdaq minimum bid

$1.00 per share

Required closing bid price for compliance

Compliance period

180 calendar days

Initial period to regain Nasdaq bid price compliance

Compliance days needed

10 consecutive business days

Minimum period at or above $1.00 bid price

Historical Context

5 past events · Latest: 2026-01-28

5 events

1. 2026-01-28

   Percentil Amazon expansion

   24h Move

   -3.6%

   Percentil began selling curated second-hand fashion via Amazon Spain.

2. 2026-01-14

   APAC focus expansion

   24h Move

   -11.0%

   Company expanded strategic focus on APAC for AI fashion technology demand.

3. 2026-01-13

   Data intelligence exploration

   24h Move

   +15.7%

   Outlined exploratory plans to monetize anonymized data via a framework.

4. 2026-01-09

   AI roll-up strategy

   24h Move

   +3.5%

   Announced AI roll-up strategy targeting complementary tech and commerce assets.

5. 2025-12-29

   Prior CEO letter

   24h Move

   -2.8%

   CEO detailed multi-business platform and 2025–2026 revenue and cash context.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

closing bid price, minimum bid price requirement, Nasdaq Listing Rules

3 terms

closing bid price financial

"the closing bid price of the Company's shares of common stock had been below $1.00"

The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.

minimum bid price requirement regulatory

"regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules"

A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.

Nasdaq Listing Rules regulatory

"regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules"

Nasdaq listing rules are the rulebook a company must follow to have its shares traded on the Nasdaq stock exchange, covering entry requirements and ongoing standards for finances, corporate governance, public disclosure and reporting. For investors they matter because the rules create baseline checks — like a driver’s license and regular inspections for a car — that promote transparency, comparability and reduce the risk of fraud or sudden delisting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

AIRPORT CITY, Israel, March 3, 2026 /PRNewswire/ -- MySize, Inc. (NASDAQ: MYSZ), a fashion-tech company built around businesses that help brands reduce returns and move inventory more efficiently, today issued a Letter to Shareholders from Ronen Luzon, Chief Executive Officer.

Dear Shareholders,

As previously announced, on March 2, 2026, MySize received a notice from The Nasdaq Stock Market stating that the closing bid price of the Company's shares of common stock had been below $1.00 for 30 consecutive trading days. In accordance with Nasdaq rules, the Company has been provided 180 calendar days, or until August 31, 2026, to regain compliance.*

The notice does not impact our operations, customers, or financial position and has no immediate effect on the listing or trading of our shares. MySize common stock continues to trade on Nasdaq under the symbol MYSZ.

We intend to regain compliance within the permitted period. Our approach is straightforward: we believe that execution is the best remedy. Our focus remains on strengthening the business, improving revenue quality, and building long-term shareholder value.

MySize generated approximately $10 million in revenue during 2025 across our platform. Orgad, our Amazon-focused overstock and infrastructure business, operated at gross margins of approximately 40% for the year ended December 31, 2025, and provided a stable revenue base. That stability gives us scale as we expand higher-margin activities.

We continue to serve enterprise clients across our sizing platform and maintain active commercial relationships across all business units.

At the same time, we are increasing the contribution of businesses that we believe can improve our overall margin profile. In September 2025, we formed 10peaks, a wholly owned regional distribution and retail subsidiary operating across Israel, Greece, Cyprus, and Malta.

10peaks has signed distribution agreements with brands including Fabletics, Rigorer, Craft, Fitvilly, and X-Bionic. The business sells through wholesale relationships, pop-up stores, and online channels. During the year ended 2025, 10peaks generated approximately $150,000 in revenue and operated at gross margins of approximately 65% before operating expenses. Based on current commercial assumptions, management estimates that the 10peaks could generate annual revenues of approximately $3 million. This estimate reflects management's current expectations and assumptions.

10peaks uses our sizing technology to deliver a better customer experience and support higher conversion and lower returns. It operates as a separate legal entity with its own management team and financial reporting, which supports accountability and flexibility as the business scales.

Beyond 10peaks, our broader platform addresses two major challenges in online fashion: returns and excess inventory.

• Naiz Fit provides AI sizing solutions that help brands reduce returns and improve conversion.
  
  
• Percentil operates a managed secondhand marketplace across key European markets.
  
  
• Orgad distributes excess and overstock inventory through Amazon and other online marketplaces.

We believe the strength of MySize is not just diversification, but how the businesses connect. Orgad provides scale, Naiz Fit improves conversion and reduces returns, Percentil monetizes excess inventory, and 10peaks adds a higher-margin commercial channel. Together, they create a more balanced and resilient company. Our strategy is simple: grow revenue, increase the share of higher-margin activities, and improve operating leverage over time.

We understand that bid price matters. The most durable way to address it is by delivering results. We remain disciplined, focused, and committed to building long-term value for our shareholders.

Sincerely,
Ronen Luzon
Founder, Chairman and Chief Executive Officer
MySize, Inc.

* To regain compliance, the bid price of the Company's common stock must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by August 31, 2026, the Company may then be eligible for additional 180 days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company does not qualify for the second compliance period or fails to regain compliance during the second compliance period, then Nasdaq will notify the Company of its determination to delist the Company's common stock, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel. The Company intends to monitor the closing bid price of its common stock and will consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

About MySize, Inc.

MySize, Inc. (NASDAQ: MYSZ) is a fashion-tech company built around businesses that help brands reduce returns and move inventory more efficiently. Naiz Fit provides AI sizing for apparel and footwear. Percentil operates a managed secondhand marketplace across key European markets. Orgad helps brands sell excess and overstock inventory online through marketplaces such as Amazon. 10peaks is a regional distribution and retail business focused on expanding commercial reach and increasing higher-margin revenue.

Estimated Preliminary Results for the Year Ending December 31, 2025 (Unaudited)

Set forth above are certain estimated preliminary financial results for the year ended December 31, 2025. These estimates are based on the information available to the company at this time. The company's actual results may differ materially from the estimated preliminary results presented due to the completion of its financial closing and accounting procedures, including final adjustments, the completion of the preparation and audit of the company's financial statements and the subsequent occurrence or identification of events prior to the filing of the audited consolidated financial statements for the fiscal year ending December 31, 2025, in the Company's Annual Report on Form 10-K. The estimated preliminary financial results have not been audited or reviewed by the company's independent registered public accounting firm. These estimates should not be viewed as a substitute for the company's full interim or annual financial statements. Accordingly, you should not place undue reliance on this preliminary data. In addition, any such statements regarding the company's financial performance are not necessarily indicative of the company's financial performance that may be expected to occur for the fiscal year ending December 31, 2025, or for any future fiscal period.

Investor Relations Contact:

Oren Elmaliah
Chief Financial Officer
MySize, Inc.
ir@mysizeid.com 
https://www.mysizeid.com

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this communication may include, among other things, statements about MySize's strategic and business plans, technology, relationships, objectives and expectations for its business, the impact of trends on and interest in its business, intellectual property or product and its future results, operations and financial performance and condition, including statements related to regaining compliance with Nasdaq's continued listing requirements, and timing and effect thereof and expectations for revenue growth. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results may differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Logo - https://mma.prnewswire.com/media/689689/3320229/MySize_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/mysize-issues-ceo-letter-to-stockholders-302702595.html

SOURCE My Size Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MySize (MYSZ) say about the Nasdaq compliance notice on March 3, 2026?

The company said it received a Nasdaq notice after shares closed below $1.00 for 30 trading days. According to the company, it has until August 31, 2026 to regain compliance by meeting the $1.00 bid requirement for 10 consecutive business days.

How much revenue did MySize (MYSZ) report for 2025 and what businesses drove it?

MySize reported approximately $10 million in 2025 revenue across its platform. According to the company, Orgad provided a stable base while Naiz Fit, Percentil, and 10peaks contributed to diversification and margin improvement efforts.

What margins did Orgad and 10peaks deliver for MySize (MYSZ) in 2025?

Orgad operated at about 40% gross margins for the year ended 2025, and 10peaks operated at about 65% gross margins before operating expenses. According to the company, these margins support higher-margin expansion plans.

What is the risk to MySize (MYSZ) if it fails to regain Nasdaq compliance by August 31, 2026?

If compliance is not regained, the company may seek an additional 180-day cure period or face delisting procedures. According to the company, failure to qualify for a second period or to cure could lead Nasdaq delisting and a hearings process.

What is management’s plan to address the sub-$1.00 bid price for MySize (MYSZ)?

Management intends to focus on execution: grow revenue, raise higher-margin activity share, and improve operating leverage. According to the company, their approach centers on strengthening business fundamentals rather than immediate corporate actions to lift the bid price.